Literature DB >> 15158693

Nitric oxide synthase inhibition during synaptic maturation decreases synapsin I immunoreactivity in rat brain.

Eduardo Sánchez-Islas1, Martha León-Olea.   

Abstract

During the development of the brain, nitric oxide and synapsins, the latter being phosphoproteins associated to presynaptic membrane vesicles, are abundant in presynaptic terminals and play important and similar roles in neurotransmitter release, morphogenesis, synaptogenesis, and synaptic plasticity. These mechanisms are fundamental for neuronal development and plasticity and constitute important factors for the formation of neuroanatomical structures. Neural nitric oxide synthase (nNOS), synapsin I, and nNOS adapter protein (CAPON) constitute a ternary complex necessary for specific NO and synapsin functions at a presynaptic level. It is not known whether NO absence may affect the presence and/or activity of synapsins during brain development. To understand the role of NO in synaptogenesis, we studied the effects of NOS inhibition on synapsin I expression at a postnatal stage. Rat pups were treated with a competitive NOS antagonist, N-nitro-L-arginine methyl ester, from postnatal days 3 to 23. Control pups received exclusively an equivalent volume of saline solution. Histochemical and immunochemical techniques for NADPH-d and synapsin I, respectively, were carried out. NOS inhibition elicited a significant reduction in synapsin I immunoreactive density and NADPH-d activity in the brain in the analyzed areas-prefrontal cortex, hippocampus, and dorsal thalamus. These data show that the alterations originated by NO and synapsin deficiencies produce a diminution in synaptic density. Thus, functions that depend on the formation of synaptic connections such as learning and memory could be affected by NO deficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158693     DOI: 10.1016/j.niox.2004.04.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  10 in total

1.  AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.

Authors:  Mark D Black; Rachel J Stevens; Nancy Rogacki; Robert E Featherstone; Yaw Senyah; Odessa Giardino; Beth Borowsky; Jeanne Stemmelin; Caroline Cohen; Philippe Pichat; Michal Arad; Segev Barak; Amaya De Levie; Ina Weiner; Guy Griebel; Geoffrey B Varty
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

Review 2.  S-nitrosation and neuronal plasticity.

Authors:  A I Santos; A Martínez-Ruiz; I M Araújo
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

3.  Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.

Authors:  Monika M Gadhia; Gary R Cutter; Steven H Abman; John P Kinsella
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

Review 4.  Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development.

Authors:  Reinaldo B Oriá; Peter D Patrick; James A Blackman; Aldo A M Lima; Richard L Guerrant
Journal:  Med Hypotheses       Date:  2006-11-13       Impact factor: 1.538

Review 5.  Nitric oxide signaling in the development and evolution of language and cognitive circuits.

Authors:  Owen H Funk; Kenneth Y Kwan
Journal:  Neurosci Res       Date:  2014-06-13       Impact factor: 3.304

6.  Neuronal NOS Induces Neuronal Differentiation Through a PKCα-Dependent GSK3β Inactivation Pathway in Hippocampal Neural Progenitor Cells.

Authors:  Shin-Young Park; Min-Jeong Kang; Joong-Soo Han
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

7.  Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

Authors:  Mark D Black; Geoffrey B Varty; Michal Arad; Segev Barak; Amaya De Levie; Denis Boulay; Philippe Pichat; Guy Griebel; Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

8.  Nitric oxide signaling modulates synaptic transmission during early postnatal development.

Authors:  Csaba Cserép; András Szonyi; Judit M Veres; Beáta Németh; Eszter Szabadits; Jan de Vente; Norbert Hájos; Tamás F Freund; Gábor Nyiri
Journal:  Cereb Cortex       Date:  2011-01-31       Impact factor: 5.357

9.  Depressed nNOS expression during spine transition in the developing hippocampus of FMR1 KO mice.

Authors:  Qin Xu; Zhiwei Zhu; Jialu Xu; Weizhong Gu; Zhengyan Zhao
Journal:  Braz J Med Biol Res       Date:  2012-10-02       Impact factor: 2.590

Review 10.  Dysregulated nitric oxide signaling as a candidate mechanism of fragile X syndrome and other neuropsychiatric disorders.

Authors:  Steven M Colvin; Kenneth Y Kwan
Journal:  Front Genet       Date:  2014-07-22       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.